Related references
Note: Only part of the references are listed.Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives
Gian Eugenio Tontini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
DELAYED-START ANALYSES OF SOLANEZUMAB PHASE 3 EXPEDITION STUDIES IN MILD ALZHEIMER'S DISEASE
Hong Liu-Seifert et al.
Alzheimers & Dementia (2014)
Adult asthma biomarkers
Mi-Ae Kim et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2014)
International European Respiratory Society/American Thoracic Society guidelines on severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials
Nicola A. Hanania et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Antiamyloid Therapy for Alzheimer's Disease - Are We on the Right Road?
Eric Karran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics
Petra Hudler et al.
SCIENTIFIC WORLD JOURNAL (2014)
Serum Periostin: A Novel Biomarker for Asthma Management
Hisako Matsumoto
ALLERGOLOGY INTERNATIONAL (2014)
Factors Contributing to an Accelerated Decline in Pulmonary Function in Asthma
Yoshihiro Kanemitsu et al.
ALLERGOLOGY INTERNATIONAL (2014)
Potential of epigenetic therapies in non-cancerous conditions
Theresa Mau et al.
FRONTIERS IN GENETICS (2014)
Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy
Nicholas C. Nicolaides et al.
FRONTIERS IN ONCOLOGY (2014)
Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and copanion diagnostics
Saumya Pant et al.
FRONTIERS IN ONCOLOGY (2014)
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens
Maddalena Riva et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2014)
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
Maria C. Carrillo et al.
ALZHEIMERS & DEMENTIA (2013)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille Abboud et al.
BLOOD (2013)
Personalizing health care: feasibility and future implications
Brian Godman et al.
BMC MEDICINE (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Remission and Persistence of Asthma Followed From 7 to 19 Years of Age
Martin Andersson et al.
PEDIATRICS (2013)
Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment
Pieter Jelle Visser et al.
BIOMARKERS IN MEDICINE (2012)
Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study
Ron L. H. Handels et al.
BMC NEUROLOGY (2012)
Personalized medicine using DNA biomarkers: a review
Andreas Ziegler et al.
HUMAN GENETICS (2012)
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Guiquan Jia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Fluid Biomarkers in Alzheimer Disease
Kaj Blennow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2011)
Biomarkers of therapy responsiveness in asthma: pitfalls and promises
S. J. H. Vijverberg et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Cytokine inhibition in severe asthma: current knowledge and future directions
Jonathan Corren
CURRENT OPINION IN PULMONARY MEDICINE (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Periostin Regulates Goblet Cell Metaplasia in a Model of Allergic Airway Inflammation
Sarita Sehra et al.
JOURNAL OF IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Stephen Holgate et al.
RESPIRATORY MEDICINE (2009)
Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses
C. Blanchard et al.
MUCOSAL IMMUNOLOGY (2008)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Asthma: defining of the persistent adult phenotypes
Sally E. Wenzel
LANCET (2006)
Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals
Go Takayama et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Share Paper
